Copy to clipboard 
Nanovation Partners and Michigan Technological University (MTU) have partnered on commercialization of processes to nano-texturize medical implants. The nanotexturing surface treatment is designed to support increased bone ingrowth and provide an antimicrobial barrier.
The partnership also broadens the company’s portfolio of five issued and 20+ pending U.S. and international patents for nanotexturing processes and structures.
To date, Nanovation has collaborated with University of California San Diego, Washington State University (WSU) and University of Central Florida on the development of development of titanium dioxide (TiO2) nanotubes for modifying the surfaces of medical implants. Researchers at MTU and WSU have been issued separate U.S. patents for nanotexturing processes and structures addressing initial and long-term infections following implantation; agreements with these institutions give Nanovation, in part, exclusive rights to license the technologies to medical device companies in all medical areas, including orthopaedics.
Further, Nanovation has also partnered with N2 Biomedical, a surface treatment provider that can perform the nanotexturing process on a service basis for interested device manufacturers.
Source: Nanovation Partners, LLC
